Syndax Pharmaceuticals (Germany) Market Value
| 1T3 Stock | EUR 12.80 0.10 0.78% |
| Symbol | Syndax |
Syndax Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Syndax Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Syndax Pharmaceuticals.
| 10/19/2024 |
| 12/18/2024 |
If you would invest 0.00 in Syndax Pharmaceuticals on October 19, 2024 and sell it all today you would earn a total of 0.00 from holding Syndax Pharmaceuticals or generate 0.0% return on investment in Syndax Pharmaceuticals over 60 days. Syndax Pharmaceuticals is related to or competes with SAFETY MEDICAL, ACCSYS TECHPLC, Apollo Medical, Japan Medical, LION ONE, Lion One, and Kaiser Aluminum. Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer More
Syndax Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Syndax Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Syndax Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.07) | |||
| Maximum Drawdown | 32.68 | |||
| Value At Risk | (5.04) | |||
| Potential Upside | 6.47 |
Syndax Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Syndax Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Syndax Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Syndax Pharmaceuticals historical prices to predict the future Syndax Pharmaceuticals' volatility.| Risk Adjusted Performance | (0.03) | |||
| Jensen Alpha | (0.41) | |||
| Total Risk Alpha | (0.59) | |||
| Treynor Ratio | (0.09) |
Syndax Pharmaceuticals Backtested Returns
Syndax Pharmaceuticals owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0523, which indicates the firm had a -0.0523% return per unit of risk over the last 3 months. Syndax Pharmaceuticals exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Syndax Pharmaceuticals' Coefficient Of Variation of (1,847), variance of 18.83, and Risk Adjusted Performance of (0.03) to confirm the risk estimate we provide. The entity has a beta of 2.83, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Syndax Pharmaceuticals will likely underperform. At this point, Syndax Pharmaceuticals has a negative expected return of -0.23%. Please make sure to validate Syndax Pharmaceuticals' variance, jensen alpha, and the relationship between the standard deviation and information ratio , to decide if Syndax Pharmaceuticals performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.65 |
Good predictability
Syndax Pharmaceuticals has good predictability. Overlapping area represents the amount of predictability between Syndax Pharmaceuticals time series from 19th of October 2024 to 18th of November 2024 and 18th of November 2024 to 18th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Syndax Pharmaceuticals price movement. The serial correlation of 0.65 indicates that roughly 65.0% of current Syndax Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.65 | |
| Spearman Rank Test | 0.52 | |
| Residual Average | 0.0 | |
| Price Variance | 0.99 |
Syndax Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Syndax Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Syndax Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Syndax Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Syndax Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Syndax Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Syndax Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Syndax Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Syndax Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Syndax Pharmaceuticals Lagged Returns
When evaluating Syndax Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Syndax Pharmaceuticals stock have on its future price. Syndax Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Syndax Pharmaceuticals autocorrelation shows the relationship between Syndax Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Syndax Pharmaceuticals.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Syndax Stock
When determining whether Syndax Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Syndax Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Syndax Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Syndax Pharmaceuticals Stock:Check out Syndax Pharmaceuticals Correlation, Syndax Pharmaceuticals Volatility and Syndax Pharmaceuticals Alpha and Beta module to complement your research on Syndax Pharmaceuticals. For more detail on how to invest in Syndax Stock please use our How to Invest in Syndax Pharmaceuticals guide.You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Syndax Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.